Drug Trial Radar · NCT06427668
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
Last checked: Nov 19, 2026Latest source record: Aug 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
24
Actual
Start
Jul 29, 2024
Primary completion
Dec 2025
Study completion Jun 2026
Sponsor
- Lead sponsor
- SpinogenixIndustry
- Sponsor type
- Industry
- First posted
- May 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 45 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 2 study will evaluate the safety, tolerability, clinical efficacy, pharmacokinetics, and pharmacodynamics of SPG302 in adult participants with mild-to-moderate AD.
Conditions
- Alzheimer Disease
Interventions
SPG302Drug
synthetic small molecule
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Electroencephalogram (EEG) at resting state and at auditory evoked P300 from baseline to endpointTime frame: 8 months
- Change in Alzheimer's Disease Assessment Scale-Cog (ADAS-COG) total score from baseline to endpointTime frame: 8 months
- Change in Mini-Mental State Examination (MMSE) from baseline to endpointTime frame: 8 months
- C-SSRS (Columbia Suicide Severity Rating Scale)Time frame: 8 months
- Change in Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change (ADCS - CGIC) from baseline to endpointTime frame: 8 months
- Change in Alzheimer's Disease Cooperative Study - Activities of Daily Living Scale from baseline to endpointTime frame: 8 months
- Quality of Life in Alzheimer's Disease (QOL-AD) from baseline to endpointTime frame: 8 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
St Vincent's Hospital
Sydney, New South Wales, Australia
Flinders Medical center
Adelaide, South Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.